Novel valproate half-sandwich rhodium and iridium conjugates to fight against multidrug-resistant Gram-positive bacteria
Open Access
- 20 June 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 52 (38) , 13482-13486
Abstract
The valproic acid conjugation to Ir(iii) and Rh(iii) half-sandwich complexes seems to switch on their antibacterial activity towards Enterococcus faecium and Staphylococcus aureus Gram-positive bacteria.Keywords
Funding Information
- Ministerio de Ciencia e Innovación
- Agencia Estatal de Investigación (PID2021-122850NB-I00)
- 'la Caixa' Foundation (LCF/PR/PR12/11070003)
- Universidad de Murcia (R-1034/2016)
- Fundación Séneca (21234/FPI/19, 21989/PI/22)
- Consejería de Educación, Junta de Castilla y León (BU305P18)
This publication has 36 references indexed in Scilit:
- Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure–Activity Relationship StudyJournal of Medicinal Chemistry, 2015
- Ruthenium complexes as antimicrobial agentsChemical Society Reviews, 2015
- An organometallic structure-activity relationship study reveals the essential role of a Re(CO)3moiety in the activity against gram-positive pathogens including MRSAChemical Science, 2014
- A Scalable Route to the SMO Receptor Antagonist SEN826: Benzimidazole Synthesis via Enhanced in Situ Formation of the Bisulfite–Aldehyde ComplexOrganic Process Research & Development, 2014
- On the antitumor properties of novel cyclometalated benzimidazole Ru(ii), Ir(iii) and Rh(iii) complexesChemical Communications, 2013
- The therapeutic journey of benzimidazoles: A reviewBioorganic & Medicinal Chemistry, 2012
- Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical SuccessJournal of Medicinal Chemistry, 2009
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Valproic Acid Enhances the Efficacy of Chemotherapy in EBV-Positive Tumors by Increasing Lytic Viral Gene ExpressionCancer Research, 2006
- Valproic AcidArchives of Neurology, 1979